Goldman Sachs’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.75M | Buy |
176,200
+15,301
| +10% | +$728K | ﹤0.01% | 3094 |
|
|
2025
Q4 | $6.01M | Buy |
160,899
+32,072
| +25% | +$1.3M | ﹤0.01% | 3578 |
|
|
2025
Q3 | $5.21M | Sell |
128,827
-62,513
| -33% | -$2.06M | ﹤0.01% | 3609 |
|
|
2025
Q2 | $4.89M | Sell |
191,340
-5,490
| -3% | -$120K | ﹤0.01% | 3443 |
|
|
2025
Q1 | $4.2M | Sell |
196,830
-47,412
| -19% | -$1.06M | ﹤0.01% | 3527 |
|
|
2024
Q4 | $5.13M | Sell |
244,242
-99,027
| -29% | -$2.29M | ﹤0.01% | 3427 |
|
|
2024
Q3 | $7.73M | Buy |
343,269
+116,334
| +51% | +$2.25M | ﹤0.01% | 2961 |
|
|
2024
Q2 | $3.81M | Buy |
226,935
+4,517
| +2% | +$72.6K | ﹤0.01% | 3408 |
|
|
2024
Q1 | $2.88M | Buy |
222,418
+27,129
| +14% | +$325K | ﹤0.01% | 3578 |
|
|
2023
Q4 | $2.26M | Buy |
195,289
+42,626
| +28% | +$481K | ﹤0.01% | 3825 |
|
|
2023
Q3 | $1.95M | Sell |
152,663
-2,400
| -2% | -$34K | ﹤0.01% | 3793 |
|
|
2023
Q2 | $2.12M | Sell |
155,063
-217,982
| -58% | -$3.12M | ﹤0.01% | 3841 |
|
|
2023
Q1 | $5.72M | Sell |
373,045
-5,913
| -2% | -$90.3K | ﹤0.01% | 2933 |
|
|
2022
Q4 | $5.08M | Buy |
378,958
+23,802
| +7% | +$319K | ﹤0.01% | 3150 |
|
|
2022
Q3 | $4.72M | Sell |
355,156
-271,081
| -43% | -$4.68M | ﹤0.01% | 3180 |
|
|
2022
Q2 | $12M | Sell |
626,237
-59,233
| -9% | -$1.12M | ﹤0.01% | 2333 |
|
|
2022
Q1 | $13.7M | Buy |
685,470
+10,065
| +1% | +$203K | ﹤0.01% | 2378 |
|
|
2021
Q4 | $13.8M | Buy |
675,405
+35,466
| +6% | +$757K | ﹤0.01% | 2467 |
|
|
2021
Q3 | $13.8M | Sell |
639,939
-8,758
| -1% | -$211K | ﹤0.01% | 2412 |
|
|
2021
Q2 | $18.7M | Buy |
648,697
+35,112
| +6% | +$950K | ﹤0.01% | 2104 |
|
|
2021
Q1 | $15M | Buy |
613,585
+242,906
| +66% | +$5.49M | ﹤0.01% | 2188 |
|
|
2020
Q4 | $7.2M | Sell |
370,679
-6,671
| -2% | -$123K | ﹤0.01% | 2708 |
|
|
2020
Q3 | $6.57M | Buy |
377,350
+84,390
| +29% | +$1.8M | ﹤0.01% | 2691 |
|
|
2020
Q2 | $7.7M | Sell |
292,960
-66,422
| -18% | -$1.65M | ﹤0.01% | 2453 |
|
|
2020
Q1 | $8.69M | Sell |
359,382
-13,901
| -4% | -$340K | ﹤0.01% | 2188 |
|
|
2019
Q4 | $9.27M | Sell |
373,283
-18,200
| -5% | -$422K | ﹤0.01% | 2487 |
|
|
2019
Q3 | $8.35M | Buy |
391,483
+52,581
| +16% | +$1.44M | ﹤0.01% | 2462 |
|
|
2019
Q2 | $10.8M | Sell |
338,902
-161,999
| -32% | -$5.08M | ﹤0.01% | 2305 |
|
|
2019
Q1 | $16.5M | Buy |
500,901
+45,881
| +10% | +$1.43M | 0.01% | 2034 |
|
|
2018
Q4 | $14.6M | Buy |
455,020
+50,597
| +13% | +$1.91M | ﹤0.01% | 2052 |
|
|
2018
Q3 | $17.4M | Sell |
404,423
-16,840
| -4% | -$796K | ﹤0.01% | 2024 |
|
|
2018
Q2 | $19.4M | Sell |
421,263
-67,130
| -14% | -$2.97M | 0.01% | 1896 |
|
|
2018
Q1 | $19.4M | Buy |
488,393
+12,002
| +3% | +$444K | 0.01% | 1884 |
|
|
2017
Q4 | $16M | Buy |
476,391
+69,063
| +17% | +$2.45M | ﹤0.01% | 2119 |
|
|
2017
Q3 | $15.1M | Buy |
407,328
+239,735
| +143% | +$9M | ﹤0.01% | 2224 |
|
|
2017
Q2 | $6.21M | Buy |
167,593
+103,497
| +161% | +$3.38M | ﹤0.01% | 2883 |
|
|
2017
Q1 | $1.8M | Buy |
64,096
+8,157
| +15% | +$230K | ﹤0.01% | 3853 |
|
|
2016
Q4 | $1.64M | Buy |
55,939
+43,663
| +356% | +$1.19M | ﹤0.01% | 4037 |
|
|
2016
Q3 | $334K | Sell |
12,276
-80,731
| -87% | -$1.83M | ﹤0.01% | 5395 |
|
|
2016
Q2 | $1.74M | Buy |
93,007
+8,997
| +11% | +$188K | ﹤0.01% | 3743 |
|
|
2016
Q1 | $2.27M | Sell |
84,010
-40,566
| -33% | -$1.16M | ﹤0.01% | 3356 |
|
|
2015
Q4 | $3.75M | Buy |
124,576
+47,469
| +62% | +$1.52M | ﹤0.01% | 3101 |
|
|
2015
Q3 | $2.44M | Buy |
77,107
+20,127
| +35% | +$735K | ﹤0.01% | 3600 |
|
|
2015
Q2 | $2.22M | Sell |
56,980
-30,490
| -35% | -$1.05M | ﹤0.01% | 3734 |
|
|
2015
Q1 | $3.1M | Buy |
+87,470
| New | +$2.82M | ﹤0.01% | 3360 |
|
Other funds holding PAHC
VCM
VPM
N
Goldman Sachs's PAHC Position: Q1 2026 in Review
Goldman Sachs increased its Phibro Animal Health (PAHC) stake by 9.5% in Q1 2026, buying an estimated $728K and bringing the position to 176,200 shares worth $9.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3094.
Goldman Sachs first reported a position in PAHC in Q1 2015 and has held it in 45 quarters since. The position peaked at $19.4M in Q2 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Goldman Sachs held 176,200 shares of Phibro Animal Health worth $9.75M as of Q1 2026.
- Goldman Sachs bought 15,301 Phibro Animal Health shares in Q1 2026, an estimated $728K.
- Phibro Animal Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3094 holding.
- Goldman Sachs first reported a position in Phibro Animal Health in Q1 2015 and has held it in 45 quarters since.
- Goldman Sachs's Phibro Animal Health position peaked at $19.4M in Q2 2018.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.